Neuroendocrine Regulation of Nutrient Partitioning
- 1 November 1999
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 892 (1) , 261-271
- https://doi.org/10.1111/j.1749-6632.1999.tb07800.x
Abstract
Leptin is a satiety factor which acts within the hypothalamus to decrease the levels of several neuropeptides stimulating food intake (among them, neuropeptide Y [NPY]), while increasing those that inhibit food intake. These effects of leptin bring about decreased body weight. In vivo, leptin potentiates basal and insulin-stimulated glucose utilization, presumably its oxidation, and decreases fat storage. Leptin increases sympathetic-mediated energy dissipation, and the expression of uncoupling proteins-1, -2, and -3. In peripheral tissues (muscles, adipose, others), leptin decreases triglyceride content by increasing fatty acid oxidation, decreasing the activity/expression of esterification and lipogenic enzymes, and favoring lipolysis. It decreases the lipogenic activity of insulin. Ultimately, leptin depletes fat stores and promotes leanness. NPY, taken as one example of what an orexigenic agent may produce, increases food intake and body weight. It favors fat storage in adipose tissue by stimulating lipogenic activity. It decreases glucose utilization by muscles, making more glucose carbon available for lipogenesis. Effects of NPY result from vagus nerve-mediated hyperinsulinemia and overactivity of the hypothalamo-pituitary-adrenal axis. Thus, NPY favors fat stores, and ultimately obesity. Glucocorticoids are necessary for NPY effects to occur, because central administration of the neuropeptide in adrenalectomized animals is ineffective. Glucocorticoids also have genuine effects when administered centrally to normal rats. They increase the hypothalamic content of NPY and decrease that of CRH. This double neuropeptidic change stimulates food intake, insulin output, adipose tissue storage ability, decreases the expression of uncoupling proteins-1 and -3, and increases body weight. Body weight homeostasis appears to require a finely tuned regulation of both leptin and glucocorticoids, with their respective opposite effects.Keywords
This publication has 70 references indexed in Scilit:
- Agouti/Melanocortin Interactions with Leptin Pathways in ObesityNutrition Reviews, 2009
- Leptin Increases Glucose Transport and Utilization in Skeletal Muscle in VitroGeneral Pharmacology: The Vascular System, 1998
- Leptin inhibits insulin-stimulated incorporation of glucose into lipids and stimulates glucose decarboxylation in isolated rat adipocytesJournal of Endocrinology, 1998
- Leptin selectively decreases visceral adiposity and enhances insulin action.Journal of Clinical Investigation, 1997
- The Loop System Between Neuropeptide Y and Leptin in Normal and Obese RodentsHormone and Metabolic Research, 1996
- Identification of targets of leptin action in rat hypothalamus.Journal of Clinical Investigation, 1996
- Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db MiceCell, 1996
- Abnormal splicing of the leptin receptor in diabetic miceNature, 1996
- The role of neuropeptide Y in the antiobesity action of the obese gene productNature, 1995
- Insulin in the brain: a hormonal regulator of energy balanceEndocrine Reviews, 1992